1223 related articles for article (PubMed ID: 29372247)
1. Association of Intracerebral Hemorrhage Among Patients Taking Non-Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality.
Inohara T; Xian Y; Liang L; Matsouaka RA; Saver JL; Smith EE; Schwamm LH; Reeves MJ; Hernandez AF; Bhatt DL; Peterson ED; Fonarow GC
JAMA; 2018 Feb; 319(5):463-473. PubMed ID: 29372247
[TBL] [Abstract][Full Text] [Related]
2. Clinical Characteristics and Outcomes Associated With Oral Anticoagulant Use Among Patients Hospitalized With Intracerebral Hemorrhage.
Xian Y; Zhang S; Inohara T; Grau-Sepulveda M; Matsouaka RA; Peterson ED; Piccini JP; Smith EE; Sheth KN; Bhatt DL; Fonarow GC; Schwamm LH
JAMA Netw Open; 2021 Feb; 4(2):e2037438. PubMed ID: 33591368
[TBL] [Abstract][Full Text] [Related]
3. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA
JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848
[TBL] [Abstract][Full Text] [Related]
4. Association of Preceding Antithrombotic Treatment With Acute Ischemic Stroke Severity and In-Hospital Outcomes Among Patients With Atrial Fibrillation.
Xian Y; O'Brien EC; Liang L; Xu H; Schwamm LH; Fonarow GC; Bhatt DL; Smith EE; Olson DM; Maisch L; Hannah D; Lindholm B; Lytle BL; Pencina MJ; Hernandez AF; Peterson ED
JAMA; 2017 Mar; 317(10):1057-1067. PubMed ID: 28291892
[TBL] [Abstract][Full Text] [Related]
5. Association of Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants With Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase.
Kam W; Holmes DN; Hernandez AF; Saver JL; Fonarow GC; Smith EE; Bhatt DL; Schwamm LH; Reeves MJ; Matsouaka RA; Khan YM; Unverdorben M; Birmingham MC; Lyden PD; Asimos AW; Altschul D; Schoonover TL; Jumaa MA; Nomura JT; Suri MFK; Moore SA; Lafranchise EF; Olson D; Peterson ED; Xian Y
JAMA; 2022 Feb; 327(8):760-771. PubMed ID: 35143601
[TBL] [Abstract][Full Text] [Related]
6. Vitamin K antagonists but not non-vitamin K antagonists in addition on antiplatelet therapy should be associated with increase of hematoma volume and mortality in patients with intracerebral hemorrhage: A sub-analysis of PASTA registry study.
Nomura K; Suda S; Abe A; Iguchi Y; Yagita Y; Kanzawa T; Okubo S; Fujimoto S; Kimura K;
J Neurol Sci; 2023 May; 448():120643. PubMed ID: 37028263
[TBL] [Abstract][Full Text] [Related]
7. Intracerebral Hemorrhagic Expansion Occurs in Patients Using Non-Vitamin K Antagonist Oral Anticoagulants Comparable with Patients Using Warfarin.
Melmed KR; Lyden P; Gellada N; Moheet A
J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1874-1882. PubMed ID: 28647419
[TBL] [Abstract][Full Text] [Related]
8. Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study.
Chao TF; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA
Circulation; 2018 Jul; 138(1):37-47. PubMed ID: 29490992
[TBL] [Abstract][Full Text] [Related]
9. Intracerebral Hematoma Occurring During Warfarin Versus Non-Vitamin K Antagonist Oral Anticoagulant Therapy.
Takahashi H; Jimbo Y; Takano H; Abe H; Sato M; Fujii Y; Aizawa Y
Am J Cardiol; 2016 Jul; 118(2):222-5. PubMed ID: 27289294
[TBL] [Abstract][Full Text] [Related]
10. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
[TBL] [Abstract][Full Text] [Related]
11. Post-Intracranial Hemorrhage Antithrombotic Therapy in Patients With Atrial Fibrillation.
Lin SY; Chang YC; Lin FJ; Tang SC; Dong YH; Wang CC
J Am Heart Assoc; 2022 Mar; 11(6):e022849. PubMed ID: 35243876
[TBL] [Abstract][Full Text] [Related]
12. Intracerebral hemorrhage associated with warfarin versus non-vitamin K antagonist oral anticoagulants in Asian patients.
Woo HG; Chung I; Gwak DS; Kim BK; Kang JH; Kim BJ; Bae HJ; Han MK
J Clin Neurosci; 2019 Mar; 61():160-165. PubMed ID: 30587420
[TBL] [Abstract][Full Text] [Related]
13. Antithrombotic Treatment and Clinical Outcomes After Intracerebral Hemorrhage: A Retrospective Cohort Study from the Swedish Stroke Register.
Tallroth M; Udumyan R; Büki A; von Euler M
J Am Heart Assoc; 2024 May; 13(10):e034716. PubMed ID: 38726922
[TBL] [Abstract][Full Text] [Related]
14. Acute management of stroke patients taking non-vitamin K antagonist oral anticoagulants Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry: Design and rationale.
Xian Y; Hernandez AF; Harding T; Fonarow GC; Bhatt DL; Suter RE; Khan Y; Schwamm LH; Peterson ED
Am Heart J; 2016 Dec; 182():28-35. PubMed ID: 27914497
[TBL] [Abstract][Full Text] [Related]
15. Intracranial Hemorrhage Caused by Non-Vitamin K Antagonist Oral Anticoagulants (NOACs)- Multicenter Retrospective Cohort Study in Japan.
Saji N; Kimura K; Aoki J; Uemura J; Sakamoto Y
Circ J; 2015; 79(5):1018-23. PubMed ID: 25739470
[TBL] [Abstract][Full Text] [Related]
16. Use of Intravenous Recombinant Tissue Plasminogen Activator in Patients With Acute Ischemic Stroke Who Take Non-Vitamin K Antagonist Oral Anticoagulants Before Stroke.
Xian Y; Federspiel JJ; Hernandez AF; Laskowitz DT; Schwamm LH; Bhatt DL; Smith EE; Fonarow GC; Peterson ED
Circulation; 2017 Mar; 135(11):1024-1035. PubMed ID: 28119380
[TBL] [Abstract][Full Text] [Related]
17. Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage.
Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GYH; Larsen TB
Stroke; 2019 Apr; 50(4):939-946. PubMed ID: 30869568
[TBL] [Abstract][Full Text] [Related]
18. Association Between Use of Non-Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation.
Chang SH; Chou IJ; Yeh YH; Chiou MJ; Wen MS; Kuo CT; See LC; Kuo CF
JAMA; 2017 Oct; 318(13):1250-1259. PubMed ID: 28973247
[TBL] [Abstract][Full Text] [Related]
19. Risk of Bleeding Following Non-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Acute Ischemic Stroke Treated With Alteplase.
Tsai TY; Liu YC; Huang WT; Tu YK; Qiu SQ; Noor S; Huang YC; Chou EH; Lai EC; Huang HK
JAMA Intern Med; 2024 Jan; 184(1):37-45. PubMed ID: 37983035
[TBL] [Abstract][Full Text] [Related]
20. Clinical and radiological course of intracerebral haemorrhage associated with the new non-vitamin K anticoagulants.
von der Brelie C; Doukas A; Naumann R; Dempfle A; Larsen N; Synowitz M; Jansen O; Mehdorn M; Jadik S
Acta Neurochir (Wien); 2017 Jan; 159(1):101-109. PubMed ID: 27873051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
